1. MiR-144 Inhibits Tumor Growth and Metastasis in Osteosarcoma via Dual-suppressing RhoA/ROCK1 Signaling Pathway
- Author
-
Wei Dong Tao, Jinlong Liu, Peng Lei Cui, Jing Li, Fei Xiao, Xiaodong Chen, Xiaoling Zhang, Zhi Guang Qiao, and Jia Jia Xu
- Subjects
Adult ,Male ,0301 basic medicine ,RHOA ,Down-Regulation ,Bone Neoplasms ,Metastasis ,Young Adult ,03 medical and health sciences ,0302 clinical medicine ,Cell Movement ,Cell Line, Tumor ,medicine ,Humans ,ROCK1 ,Neoplasm Metastasis ,Protein kinase A ,Cell Proliferation ,Pharmacology ,Osteosarcoma ,rho-Associated Kinases ,biology ,Cell growth ,Chemistry ,medicine.disease ,Up-Regulation ,MicroRNAs ,030104 developmental biology ,Cell culture ,Disease Progression ,Cancer research ,biology.protein ,Molecular Medicine ,Female ,Signal transduction ,rhoA GTP-Binding Protein ,030217 neurology & neurosurgery ,Signal Transduction - Abstract
Several microRNAs (miRNAs) have been found expressed differentially in osteosarcoma (OS), so they may function in the onset and progression of OS. In this study, we found that miR-144 significantly suppresses osteosarcoma cell proliferation, migration, and invasion ability in vitro and inhibited tumor growth and metastasis in vivo. Mechanically, we demonstrated that Ras homolog family member A (RhoA) and its pivotal downstream effector Rho-associated, coiled-coil-containing protein kinase 1 (ROCK1) were direct targets of miR-144. Moreover, the negative correlation between down-regulated miR-144 and up-regulated ROCK1/RhoA was verified in both OS cell lines and clinical patients' specimens. Functionally, RhoA with or without ROCK1 co-overexpression resulted a rescue phenotype on miR-144 inhibited cell growth, migration, and invasion abilities whereas individual overexpression of ROCK1 had no statistical significance compared with controls in miR-144-transfected SAOS2 and U2-OS cells. Taken together, this study demonstrates that miR-144 inhibited tumor growth and metastasis in OS via dual-suppressing of RhoA and ROCK1, which could be a new therapeutic approach for the treatment of OS.
- Published
- 2019
- Full Text
- View/download PDF